The Federal Government’s partnership with local drug manufacturers will ensure the availability, accessibility, affordability of qualitative medicines to Nigerians.
The $9.2 million is to help the country scale-up COVID-19 vaccine service delivery, particularly to the most vulnerable and unreached. Fifteen states will benefit from the grant.